Proteomics, Genomics, Bioinformatics, and Cancer Genetics: Advanced Topics in Modern Genetics

Proteomics: Protein Structure and Function

Levels of Protein Structure

Proteins are complex macromolecules essential for cellular structure and function. Their structure is organized into four hierarchical levels:

• Primary Structure: The linear sequence of amino acids in a polypeptide chain, determined by the gene encoding the protein.

• Secondary Structure: Local folding patterns stabilized by hydrogen bonds, including the alpha helix and beta-pleated sheet.

• Tertiary Structure: The overall three-dimensional conformation of a single polypeptide chain, resulting from interactions among R-groups.

• Quaternary Structure: The association of multiple polypeptide chains (subunits) into a functional protein complex.

Diversity of Protein Functions

• Immunoglobulins: Antibodies that function in the immune response of vertebrates.

• Transport Proteins: Facilitate movement of molecules across cellular membranes (e.g., hemoglobin).

• Hormones and Receptors: Regulate physiological processes by signaling and response mechanisms.

• Histones: Bind to DNA and play a role in chromatin structure in eukaryotes.

• Transcription Factors: Regulate gene expression by binding to specific DNA sequences.

Enzymes

Enzymes are proteins that catalyze biochemical reactions, increasing reaction rates and determining the metabolic capacity of cells. They are highly specific and essential for life.

Sickle-Cell Anemia: A Molecular Disease

Sickle-cell anemia is a recessive genetic disorder caused by a mutation in the beta-globin gene of hemoglobin (HbS allele). Homozygous individuals exhibit sickle-shaped erythrocytes under low oxygen tension, leading to various health complications. Heterozygotes are typically asymptomatic carriers.

Example: The substitution of valine for glutamic acid at position 6 in the beta chain of hemoglobin causes the sickling phenotype.

Genomics and Bioinformatics

Polymerase Chain Reaction (PCR)

PCR is a rapid, in vitro method for amplifying specific DNA sequences, eliminating the need for host cells in cloning. It is widely used in research, diagnostics, and forensics.

• Requirements: Double-stranded target DNA, DNA polymerase, Mg2+ ions, four deoxyribonucleoside triphosphates, and two primers (complementary to the 5' and 3' ends of the target sequence).

• Applications: Amplification from minimal DNA sources such as dried blood, semen, or hair.

Genomics

Genomics is the comprehensive study of genomes, providing insights into gene structure, function, and evolution. It is one of the fastest-growing fields in genetics.

Bioinformatics

Bioinformatics utilizes mathematical and computational tools to organize, analyze, and interpret biological data, including gene sequences, expression profiles, and protein structures.

• Applications include comparing DNA sequences, identifying genes and regulatory regions, predicting protein sequences, and deducing evolutionary relationships.

Next-Generation Sequencing (NGS)

NGS technologies enable simultaneous sequencing of thousands of DNA molecules, generating vast amounts of data quickly and cost-effectively using fluorescence imaging.

GenBank and Genome Databases

GenBank, maintained by the NCBI, is the largest public DNA sequence database. Each entry receives a unique accession number for retrieval and analysis. Comparative genomics can reveal evolutionary conservation between species, as seen in the similarity between human LEP and mouse Lep genes.

The Genetics of Cancer

Cancer as a Genetic Disease

Cancer arises from genetic alterations in somatic cells, including point mutations, chromosomal rearrangements, amplifications, and deletions. Only a small percentage of cancers are due to inherited (germ-line) mutations.

Chromosomal Translocations in Cancer

Reciprocal chromosomal translocations are common in cancers such as leukemias and lymphomas. For example, the Philadelphia chromosome in chronic myelogenous leukemia (CML) results from a t(9;22) translocation, creating a fusion gene that drives uncontrolled cell division.

Properties of Cancer Cells

• Proliferation: Uncontrolled cell growth and division.

• Metastasis: Spread of cancer cells to other tissues, forming secondary tumors.

• Benign Tumors: Non-invasive, localized growths.

• Malignant Tumors: Invasive, metastatic, and life-threatening.

The cancer stem cell hypothesis suggests that only a subset of tumor cells (cancer stem cells) can initiate new tumors due to their self-renewal capacity.

Multistep Nature of Cancer Development

Cancer develops through the accumulation of multiple mutations over time, often taking decades to progress from normal cells to malignant tumors. This is exemplified in colorectal cancer, where sequential driver mutations lead to tumorigenesis.

Genomic Instability and Mutator Phenotype

Cancer cells exhibit high rates of mutation and chromosomal abnormalities, including translocations, aneuploidy, and deletions. This genomic instability increases the likelihood of acquiring additional cancer-promoting mutations.

Proto-oncogenes and Tumor-Suppressor Genes

Proto-oncogenes promote cell growth and division; mutations can convert them into oncogenes, driving cancer. Tumor-suppressor genes inhibit cell division or promote apoptosis; their inactivation removes growth restraints.

Gene	Normal Function	Alteration in Cancer	Associated Cancers
c-myc	Transcription factor, regulates cell cycle, differentiation, apoptosis	Translocation, amplification, point mutations	Lymphomas, leukemias, lung cancer, many types
c-kit	Tyrosine kinase, signal transduction	Mutation	Sarcomas
RARα	Hormone-dependent transcription factor, differentiation	Chromosomal translocations with PML gene, fusion product	Acute promyelocytic leukemia
Cyclins	Bind to CDKs, regulate cell cycle	Gene amplification, overexpression	Lung, esophagus, many types
RB1	Cell-cycle checkpoints, binds E2F	Mutation, deletion, inactivation by viral oncogene products	Retinoblastoma, osteosarcoma, many types
TP53	Transcription regulation	Mutation, deletion, viruses	Many types
BRCA1, BRCA2	DNA repair	Point mutations	Breast, ovarian, prostate cancers

TP53: The Guardian of the Genome

TP53 encodes the p53 protein, a transcription factor that regulates cell cycle arrest and apoptosis in response to DNA damage. Mutations in TP53 are found in about 50% of all cancers, leading to loss of cell cycle control and increased mutation rates.

Inherited Cancer Predisposition Syndromes

Tumor Predisposition Syndrome	Chromosome	Gene Affected
Early-onset familial breast cancer	17q	BRCA1
Familial adenomatous polyposis	5q	APC
Familial melanoma	9p	CDKN2
Gorlin syndrome	9q	PTCH1
Hereditary nonpolyposis colon cancer	2p	MSH2, 6
Li-Fraumeni syndrome	17p	TP53
Multiple endocrine neoplasia, type 1	11q	MEN1
Multiple endocrine neoplasia, type 2	10q	RET
Neurofibromatosis, type 1	17q	NF1
Neurofibromatosis, type 2	22q	NF2
Retinoblastoma	13q	pRb
Von Hippel–Lindau syndrome	3p	VHL
Wilms tumor	11p	WT1

Carcinogens and Cancer Risk

Carcinogens are agents that cause cancer, often with a long latency period. Examples include aflatoxin, nitrosamines, tobacco smoke, and certain viruses. Tobacco smoke is associated with multiple cancer types and induces both genetic and epigenetic changes.

Viruses and Cancer

Virus	Associated Cancers
Epstein-Barr virus (EBV)	Burkitt lymphoma, nasopharyngeal carcinoma, Hodgkin lymphoma
Hepatitis B virus (HBV)	Hepatocellular carcinoma
Hepatitis C virus (HCV)	Hepatocellular carcinoma, non-Hodgkin lymphoma
Human papilloma viruses 16, 18 (HPV16, 18)	Cervical cancer, anogenital cancers, oral cancers
Kaposi sarcoma–associated herpesvirus (KSHV)	Kaposi sarcoma, primary effusion lymphoma
Human T-cell lymphotropic virus, type 1 (HTLV-1)	Adult T-cell leukemia and lymphoma
Human immunodeficiency virus, type 1 (HIV-1)	Immune suppression, leading to cancers caused by other viruses (KSHV, EBV, HPV)

Genome Editing with CRISPR-Cas

CRISPR-Cas9 Technology

Genome editing involves the precise removal, addition, or alteration of DNA sequences in living cells. The CRISPR-Cas9 system, adapted from bacterial immune defense, is the most efficient and versatile genome editing tool.

• An sgRNA guides the Cas9 nuclease to a specific DNA sequence adjacent to a PAM site, where it introduces a double-stranded break.

• Repair can occur via non-homologous end joining (NHEJ), introducing indels, or homology-directed repair (HDR), allowing precise edits using a donor template.

Applications of CRISPR-Cas

• Crop improvement (e.g., faster-ripening tomatoes, enhanced nutritional traits)

• Gene therapy for genetic diseases and cancer (clinical trials underway)

• Potential de-extinction projects (e.g., woolly mammoth)

• Livestock disease resistance